CLINICAL STUDY
Risk of acute first myocardial infarction and use of nicotine patches in a general population
Stephen E. Kimmel, MD, MS, FACC*  ,
Jesse A. Berlin, ScD*,
Carolyn Miles, MPH*,
Jane Jaskowiak, BSN, RN*,
Jeffrey L. Carson, MD and
Brian L. Strom, MD, MPH*
* Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Cardiovascular Division, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Division of General Internal Medicine, Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
Manuscript received October 10, 2000;
revised manuscript received November 29, 2000,
accepted December 21, 2000.
Reprint requests and correspondence: Dr. Stephen E. Kimmel, University of Pennsylvania School of Medicine, Center for Clinical Epidemiology and Biostatistics, 717 Blockley Hall, 423 Guardian Drive, Philadelphia, Pennsylvania 19104-6021
skimmel{at}cceb.med.upenn.edu
OBJECTIVES
To determine if nicotine patches, both as prescribed and used over-the-counter, increase the risk of first myocardial infarction (MI).
BACKGROUND
Although nicotine patches improve smoking cessation rates, case reports have raised the hypothesis that they may increase the risk of MI.
METHODS
A population-based case-control study among 68 hospitals in an eight-county region surrounding Philadelphia was performed to determine if nicotine patches increase the risk of first MI. Cases were smokers (current or within the prior year) admitted to all hospitals in the region with a first MI. Controls were smokers (current or within the prior year) without prior MI selected from the same region using random-digit dialing. Data were collected by telephone interviews and chart reviews. The study had 80% power to detect an odds ratio (OR) of 2.5.
RESULTS
A total of 653 cases and 2,990 controls were interviewed. There was no association between nicotine patches and MI (OR 0.46; 95% CI: 0.09, 1.47), and the confidence interval (CI) excluded an effect from nicotine patches equal to that from cigarette smoking itself (OR < 2.5). Among those who abstained from smoking, the OR for use of nicotine patches was 0.25 (95% CI: 0.01, 1.67); among those who smoked concomitantly, the OR for patch use was 0.83 (95% CI: 0.09, 3.81). Adjustment for confounding did not alter the study’s findings (OR adjusted for confounders that could mask a harmful effect of patches: 0.70; 95% CI: 0.20, 2.46).
CONCLUSIONS
Nicotine patches, as used in actual practice, do not appear to be associated with an increased risk of MI.
|
Abbreviations and Acronyms
| | CI | = confidence interval | | MI | = myocardial infarction | | OR | = odds ratio |
|
This article has been cited by other articles:
|
|
|
|
 
B. J. Apelberg, G. Onicescu, E. Avila-Tang, and J. M. Samet
Estimating the Risks and Benefits of Nicotine Replacement Therapy for Smoking Cessation in the United States
Am J Public Health,
February 1, 2010;
100(2):
341 - 348.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. H. Frishman
Smoking cessation pharmacotherapy
Therapeutic Advances in Cardiovascular Disease,
August 1, 2009;
3(4):
287 - 308.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. J. Ossip, S. M. Abrams, M. C. Mahoney, D. Sall, and K. M. Cummings
Adverse effects with use of nicotine replacement therapy among quitline clients
Nicotine Tob Res,
April 1, 2009;
11(4):
408 - 417.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. L. Ford and J. A. Zlabek
Nicotine Replacement Therapy and Cardiovascular Disease
Mayo Clin. Proc.,
May 1, 2005;
80(5):
652 - 656.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. P. Winickoff, S. E. Tanski, R. C. McMillen, J. D. Klein, N. A. Rigotti, and M. Weitzman
Child Health Care Clinicians' Use of Medications to Help Parents Quit Smoking: A National Parent Survey
Pediatrics,
April 1, 2005;
115(4):
1013 - 1017.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Winickoff, A. B. Berkowitz, K. Brooks, S. E. Tanski, A. Geller, C. Thomson, H. A. Lando, S. Curry, M. Muramoto, A. V. Prokhorov, et al.
State-of-the-Art Interventions for Office-Based Parental Tobacco Control
Pediatrics,
March 1, 2005;
115(3):
750 - 760.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Gupta, H. Gurm, and J. R. Bartholomew
Smokeless Tobacco and Cardiovascular Risk
Arch Intern Med,
September 27, 2004;
164(17):
1845 - 1849.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Suzuki, E. Bayna, E. Dalle Molle, and W. Y. W. Lew
Nicotine inhibits cardiac apoptosis induced by lipopolysaccharide in rats
J. Am. Coll. Cardiol.,
February 5, 2003;
41(3):
482 - 488.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. H. Sauer, J. A. Berlin, B. L. Strom, C. Miles, J. L. Carson, and S. E. Kimmel
Cigarette Yield and the Risk of Myocardial Infarction in Smokers
Arch Intern Med,
February 11, 2002;
162(3):
300 - 306.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. H. Sauer, J. A. Berlin, and S. E. Kimmel
Selective Serotonin Reuptake Inhibitors and Myocardial Infarction
Circulation,
October 16, 2001;
104(16):
1894 - 1898.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. T KOZLOWSKI, A. A STRASSER, G. A GIOVINO, P. A ERICKSON, and J. V TERZA
Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction
Tob. Control,
September 1, 2001;
10(3):
201 - 203.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Nicotine Patches and Risk for First Myocardial Infarction
Journal Watch Psychiatry,
July 11, 2001;
2001(711):
8 - 8.
[Full Text]
|
|
|
|
|
|
|
Nicotine Patches and Risk for First Myocardial Infarction
Journal Watch (General),
May 22, 2001;
2001(522):
6 - 6.
[Full Text]
|
|
|
|
|
|
|
Nicotine Patches Do Not Increase MI Risk
Journal Watch Cardiology,
May 18, 2001;
2001(518):
6 - 6.
[Full Text]
|
|
|
|
